Published Health Economics Study Shows a High Disease Burden Associated with Stress/Mixed Urinary Incontinence to U.S. Payers

by | May 23, 2023 | Posters & Publications

Veranex’s Commercial Strategy and Market Access team members, Manasi Datar, PhD, Li-Chen Pan, MPH, and Thomas F. Goss, PharmD, along with members from Renovia, Inc. successfully published a peer-reviewed manuscript in Neurology and Urodynamics highlighting the significantly high healthcare resource utilization and costs in female patients diagnosed with stress or mixed urinary incontinence (SUI/MUI). This evidence suggests that more effective treatments are needed for women suffering from this condition and urges payers to increase access to innovative treatments in this population.